My Account Log in

4 options

Medullary Thyroid Carcinoma : Biology - Management - Treatment / edited by Friedhelm Raue.

Connect to full text Available online

View online
LIBRA RC261 .R35 v.1 (1965)-v.5 (1966), v.7 (1966)-v.98 (1985), v.100 (1986)-v.121 (1991), v.123 (1991)-v.126 (1993), v.128 (1993)-v.158 (2000); v.13:2nd ed. (1976) 1969
Loading location information...

Available from offsite location This item is stored in our repository but can be checked out.

Log in to request item
Holman Biotech Commons - Periodicals Per. v.159 (2002)-184,186,188-189,191-192,194-196
Loading location information...

Mixed Availability Some items are available, others may be requested.

Log in to request item
Levy Dental Medicine Library - Stacks RC261 .R35 149
Loading location information...

Mixed Availability Some items are available, others may be requested.

Log in to request item
Format:
Book
Contributor:
Raue, F. (Friedhelm), editor.
SpringerLink (Online service)
Series:
Recent results in cancer research 0080-0015 ; 204.
Recent results in cancer research
Language:
English
Subjects (All):
Medicine.
Human genetics.
Nuclear medicine.
Endocrinology.
Oncology.
Physical Description:
1 online resource.
Edition:
First edition 2015.
Contained In:
Springer eBooks
Place of Publication:
Cham : Springer International Publishing : Imprint: Springer, 2015.
System Details:
Mode of Access: World Wide Web.
text file PDF
Summary:
This book offers a comprehensive overview of medullary thyroid carcinoma, both in the more common sporadic form and in the familial form, multiple endocrine neoplasia (MEN) types 2A and 2B. The coverage includes, but is not limited to, molecular biology and genetics, pathology, clinical presentation, imaging techniques, surgical treatment, and follow-up. The role of calcitonin as a highly sensitive and specific tumor marker for the screening, diagnosis, and follow-up of MTC and metastatic disease is described, and the significance of other tumor markers is also considered. With regard to treatment, the use of thyroidectomy is fully discussed, including in children carrying the mutations in the RET proto-oncogene considered causative for MEN 2. Additionally, the value of tyrosine kinase inhibitors as the most effective treatment modality in patients with a large tumor burden or rapid tumor growth, or both, is explained. Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2 will be an ideal source of up-to-date information for a wide range of practitioners, including endocrinologists, oncologists, internal medicine specialists, geneticists, and nuclear medicine physicians.
Contents:
Thyroid C-Cell Biology and Oncogenic Transformation
Histopathology of C cells and medullary thyroid carcinoma
Epidemiology and clinical presentation of Medullary Thyroid Carcinoma
Medullary thyroid carcinoma: Imaging
Calcitonin as a Biomarker for Medullary Thyroid Carcinoma
Hereditary Medullary Thyroid Cancer, Genotype phenotype correlation
Pheochromocytomas in Multiple Endocrine Neoplasia 2
Primary hyperparathyroidism in Multiple Endocrine Neoplasia 2 Syndrome
Surgical treatment of medullary thyroid carcinoma
Long term follow up in medullary thyroid carcinoma
Use of Tyrosine Kinase Inhibitors for Treatment of Medullary Thyroid Carcinoma.
Other Format:
Printed edition:
ISBN:
9783319225425
Access Restriction:
Restricted for use by site license.

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account